Mirae Asset Global Etfs Holdings Ltd. Alnylam Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 13,953 shares of ALNY stock, worth $4.27 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,953
Previous 14,731
5.28%
Holding current value
$4.27 Million
Previous $3.47 Million
8.68%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ALNY
# of Institutions
721Shares Held
111MCall Options Held
978KPut Options Held
881K-
Capital World Investors Los Angeles, CA16.7MShares$5.13 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$4 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.92 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.19 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.35 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $37.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...